Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2011

View Archived Issues

Eli Lilly provides update on strategy and pipeline

New full dopamine D3 receptor agonist CJ-1639 displays potent and selective activity in vivo

New synthetic aminoglycoside NB-54 shows preclinical potential as Rett syndrome therapy

First potential diagnostic marker for Churg-Strauss syndrome identified

Mitsubishi Tanabe Pharma discloses new antiplatelet agents

Lundbeck patents new phosphodiesterase 10A inhibitors

Scynexis patents new ciclosporin derivatives for hepatitis C

Pierre Fabre Medicament discloses new sucrose octasulfates of zinc

New hepatocyte growth factor receptor inhibitors presented

Boehringer Ingelheim claims new inhibitors of ribosomal protein S6 kinase alpha-3

Merck Serono's new prostanoid DP2 receptor antagonist shows potential to treat asthma

Sanofi discontinues Multaq trial in patients with permanent atrial fibrillation

Pfizer Japan and Astellas Pharma revise copromotion agreement for Caduet

GSK announces regulatory update for Votrient in advanced soft tissue sarcoma

Onconova and SymBio enter license agreement for rigosertib in Japan and Korea

Sanofi and Genzyme report encouraging phase III data on alemtuzumab in MS

Generex reports preliminary results from two trials of its mealtime insulin Generex Oral-lyn

Valeant Pharmaceuticals to acquire Sanofi's Dermik dermatology unit

Coronado Biosciences secures funds to advance CNDO-201 and CNDO-109

Qiagen increases offer price for acquisition of Cellestis

HUYA Bioscience and Liaoning (Benxi) Bio-pharmaceutical Industry Base enter strategic partnership

Qiagen enters binding agreement to acquire majority stake in Ipsogen

Amarin completes nonclinical studies for AMR-101 NDA

Alkermes discontinues development of ALKS-33 in binge eating disorder based on phase II data

FDA approves Boostrix vaccine for persons over 65 years of age

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...